Pandemics

Required Travel Insurance Becoming More Popular, says Squaremouth

Retrieved on: 
Wednesday, July 28, 2021
Contemporary history, COVID-19 pandemic, Occupational safety and health, Pandemics, Public Health Emergency of International Concern, Insurance, Infectious diseases, Articles

Since the onset of the Covid-19 pandemic, 18 countries have begun requiring visitors travel with insurance for Covid-19.

Key Points: 
  • Since the onset of the Covid-19 pandemic, 18 countries have begun requiring visitors travel with insurance for Covid-19.
  • Travel insurance comparison site, Squaremouth.com , predicted this trend early on in the pandemic, and now says this may become the new norm.
  • Leveraging decades of travel expertise, and industry-leading technology, Squaremouth.com hosts the most intuitive travel insurance quoting and comparison engine on the market today.
  • Coupled with verified customer reviews and the largest portfolio of products, Squaremouth allows travelers to instantly purchase a travel insurance policy from every major provider in the US.

Insights on the Respiratory Inhalers Global Market to 2027 - Featuring AstraZeneca, Cipla and GlaxoSmithKline Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 28, 2021
Pharmaceutical, Health, Medical Supplies, Health, Contemporary history, COVID-19 pandemic, Occupational safety and health, Pandemics, Public Health Emergency of International Concern, Inhaler

The "Respiratory Inhalers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Respiratory Inhalers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Respiratory Inhalers estimated at US$33.9 Billion in the year 2020, is projected to reach a revised size of US$51 Billion by 2027, growing at a CAGR of 6% over the period 2020-2027.
  • This segment currently accounts for a 6.9% share of the global Respiratory Inhalers market.
  • The country currently accounts for a 36.11% share in the global market.

Opteev Launches the First-Ever Plug-In Airborne Virus Detector that Immediately Alerts when COVID-19, the Flu and Other Viruses Are Found

Retrieved on: 
Tuesday, July 27, 2021
Health, Medical specialties, Zoonoses, Occupational safety and health, Pandemics, Active fire protection, Americium, Smoke detector, COVID-19, Virus, Influenza

New procedures and technologies are needed to stop the spread of COVID-19 this year while allowing people to enjoy their lives.

Key Points: 
  • New procedures and technologies are needed to stop the spread of COVID-19 this year while allowing people to enjoy their lives.
  • "With ViraWarn, we're making it safer to be together indoors and helping prevent large scale virus transmission in the future."
  • Like a smoke detector monitoring the air and alerting when smoke is detected, ViraWarn monitors the air and immediately alerts when coronavirus particles are detected.
  • The patented sensor technology focuses on the unique electrochemistry of spiked protein viruses, including COVID-19 and influenza, to trigger an alert.

AHF Commends the Resumption of HIV Treatment in Kenya – But More Is Needed

Retrieved on: 
Monday, July 26, 2021
Research, General Health, Pharmaceutical, White House, Federal Government, Infectious diseases, Public policy, Other Policy Issues, Science, Biotechnology, AIDS, Health, Public policy, Government, Medical specialties, HIV/AIDS, Health, Clinical medicine, Pandemics, Hepatotoxins, Sexually transmitted diseases and infections, Viral load, HIV, Treatment as prevention, HIV and pregnancy

As a result, distribution of lifesaving HIV/AIDS prevention and treatment medications has resumed as of July 14, according to the US Embassy.

Key Points: 
  • As a result, distribution of lifesaving HIV/AIDS prevention and treatment medications has resumed as of July 14, according to the US Embassy.
  • The damage done to peoples lives and wellbeingparticularly childrens livesis irreversible and must never be repeated.
  • Ensure that HIV management is implemented holistically by taking into consideration prevention and diagnosis, care and treatment, and related essential commodities, including medications.
  • This is urgently needed to address current shortages of paediatric HIV treatment, viral load testing reagents, and HIV test kits.

CGTN Think Tank Releases an Analytical Report on the Global Situation of the COVID-19 Pandemic

Retrieved on: 
Saturday, July 24, 2021
Pandemics

The Report puts together the data on pandemic prevention and control measures in 51 sample countries to make rankings as a way of reflecting the current situation of pandemic control in these countries.

Key Points: 
  • The Report puts together the data on pandemic prevention and control measures in 51 sample countries to make rankings as a way of reflecting the current situation of pandemic control in these countries.
  • It focuses on the importance that countries attach to personal safety, social and environmental stability, thereby providing ideas and directions for countries around the world to fight the pandemic.
  • The data shows that the United States has the worst performance on three of the five statistical indicators.
  • When it comes to the total number of confirmed cases and deaths, France, the UK and Italy all rank high.

CGTN Think Tank Releases an Analytical Report on the Global Situation of the COVID-19 Pandemic

Retrieved on: 
Saturday, July 24, 2021
Pandemics

The Report puts together the data on pandemic prevention and control measures in 51 sample countries to make rankings as a way of reflecting the current situation of pandemic control in these countries.

Key Points: 
  • The Report puts together the data on pandemic prevention and control measures in 51 sample countries to make rankings as a way of reflecting the current situation of pandemic control in these countries.
  • It focuses on the importance that countries attach to personal safety, social and environmental stability, thereby providing ideas and directions for countries around the world to fight the pandemic.
  • The data shows that the United States has the worst performance on three of the five statistical indicators.
  • When it comes to the total number of confirmed cases and deaths, France, the UK and Italy all rank high.

Sinopec Builds World's Largest Disinfectant Production Base

Retrieved on: 
Friday, July 23, 2021
Contemporary history, Health, Articles, COVID-19 pandemic, Occupational safety and health, Pandemics, Public Health Emergency of International Concern, Disinfectant

QIANJIANG, China, July 23, 2021 /PRNewswire/ -- Sinopec Jianghan Salt Chemical Hubei Co., Ltd. (the "Company"), a subsidiary of China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec"), has completed a trial run of its new 12,000 tons/year concentrated bleaching powder batch feeder on July 23. At present, the Company's annual disinfectant production capacity exceeds 100,000 tons, making it the world's largest disinfectant production base.

Key Points: 
  • At present, the Company's annual disinfectant production capacity exceeds 100,000 tons, making it the world's largest disinfectant production base.
  • The Company's disinfectant products are now exported to more than 80 countries and territories.
  • The construction of the new 12,000-ton/year disinfectant production plant kicked off in June 2020 and is set to enter operation soon, despite multiple challenges, including the COVID-19 pandemic and recent floods.
  • In 2020, when Wuhan ran out of disinfectant supplies to prevent and control the novel coronavirus, Sinopec imminently instructed the Company to adjust production and ensure a sufficient supply.

Sinopec Builds World's Largest Disinfectant Production Base

Retrieved on: 
Friday, July 23, 2021
Contemporary history, Health, Articles, COVID-19 pandemic, Occupational safety and health, Pandemics, Public Health Emergency of International Concern, Disinfectant

At present, the Company's annual disinfectant production capacity exceeds 100,000 tons, making it the world's largest disinfectant production base.

Key Points: 
  • At present, the Company's annual disinfectant production capacity exceeds 100,000 tons, making it the world's largest disinfectant production base.
  • The Company's disinfectant products are now exported to more than 80 countries and territories.
  • The construction of the new 12,000-ton/year disinfectant production plant kicked off in June 2020 and is set to enter operation soon, despite multiple challenges, including the COVID-19 pandemic and recent floods.
  • In 2020, when Wuhan ran out of disinfectant supplies to prevent and control the novel coronavirus, Sinopec imminently instructed the Company to adjust production and ensure a sufficient supply.

DGAP-News: In the first half of 2021, LUDWIG BECK suffered significant sales losses again due to the COVID-19 pandemic and officially imposed restrictions

Retrieved on: 
Thursday, July 22, 2021
Contemporary history, Infectious diseases, COVID-19 pandemic, Occupational safety and health, Pandemics, Public Health Emergency of International Concern, Health, Republic of Ireland

In the first half of 2021, LUDWIG BECK suffered significant sales losses again due to the COVID-19 pandemic and officially imposed restrictions

Key Points: 
  • In the first half of 2021, LUDWIG BECK suffered significant sales losses again due to the COVID-19 pandemic and officially imposed restrictions
    The issuer is solely responsible for the content of this announcement.
  • In the first half of 2021, LUDWIG BECK suffered significant sales losses again due to the COVID-19 pandemic and officially imposed restrictions
    Munich, July 22, 2021 - After the "pandemic-year" 2020 also the first half of 2021 was heavily impacted by the COVID-19 pandemic again.
  • The LUDWIG BECK Group generated gross sales of 20.2 million in the first half of the 2021 fiscal year (previous year: 24.8 million).
  • Due to the negative sales development, LUDWIG BECK generated a net gross profit of 7.6 million (previous year: 9.1 million).

Nanopharm and Leyden Labs Announce Agreement to Develop Intranasal Spray Product Candidates for Prophylactic Use Against Known and New Respiratory Viruses

Retrieved on: 
Wednesday, July 21, 2021
Health, Medicine, Epidemiology, Pandemics, Virus, Zoonoses

Leyden Labs platform targets commonalities of viral families to develop product candidates that protect against many strains of a virus simultaneously with a single product.

Key Points: 
  • Leyden Labs platform targets commonalities of viral families to develop product candidates that protect against many strains of a virus simultaneously with a single product.
  • Nanopharm will screen and subsequently develop a liquid nasal spray formulation, including performance testing and nasal deposition studies, to prepare Leyden Labs for Phase 1 clinical studies.
  • Leyden Labs is taking a really exciting approach to finding solutions for the broad-spectrum prophylactic protection against respiratory viruses, commented Jag Shur, CEO of Nanopharm.
  • Koenraad Wiedhaup, CEO of Leyden Labs, stated, Nanopharms team has the world-leading expertise needed to understand and develop safe, effective formulations targeting respiratory viruses.